Li Lab

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2019

Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea

Yuan, X. and Li, J. and Li, Y. and Deng, Z. and Zhou, L. and Long, J. and Tang, Y. and Zuo, Z. and Zhang, Y. and Xie, H.

doi:10.1016/j.biopha.2019.109181


Abstract

Rosacea is a facial chronic inflammatory skin disease with dysfunction of immune and vascular system. Artemisinin (ART), an anti-malaria drug, was reported to have several effects including anti-inflammation and anti-angiogenesis activities. However, the role of ART on rosacea remains unclear.

← Back to publications